KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTangible Book ValueTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nova (NVMI) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Nova (NVMI) over the last 17 years, with Q3 2025 value amounting to $160.9 million.

  • Nova's Cash & Equivalents rose 449.33% to $160.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $160.9 million, marking a year-over-year increase of 449.33%. This contributed to the annual value of $157.8 million for FY2024, which is 4667.02% up from last year.
  • Per Nova's latest filing, its Cash & Equivalents stood at $160.9 million for Q3 2025, which was up 449.33% from $160.6 million recorded in Q2 2025.
  • Nova's Cash & Equivalents' 5-year high stood at $232.3 million during Q1 2021, with a 5-year trough of $72.1 million in Q3 2021.
  • In the last 5 years, Nova's Cash & Equivalents had a median value of $126.7 million in 2021 and averaged $132.8 million.
  • Per our database at Business Quant, Nova's Cash & Equivalents soared by 63171.22% in 2021 and then crashed by 5471.75% in 2022.
  • Over the past 5 years, Nova's Cash & Equivalents (Quarter) stood at $126.7 million in 2021, then fell by 11.82% to $111.7 million in 2022, then dropped by 3.71% to $107.6 million in 2023, then soared by 46.67% to $157.8 million in 2024, then increased by 1.97% to $160.9 million in 2025.
  • Its Cash & Equivalents was $160.9 million in Q3 2025, compared to $160.6 million in Q2 2025 and $141.1 million in Q1 2025.